Ester Fonsatti - Concepedia

Author

Ester Fonsatti

Also Known As

E FONSATTI, E Fonsatti, E. Fonsatti, Ester Fonsatti, Fonsatti Ester, Keith Flaherty, Maria Fortunata Lofiego, Ornella Cutaia, Vincenzo Russo

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Centro di Riferimento Oncologico University of Siena Tumori Foundation Network Italiano Per la Bioterapia Dei Tumori Medica (Italy)

About

Ester Fonsatti is an author at Centro di Riferimento Oncologico specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	1.8K
2	Cell Biology	10	10	382
3	Health Sciences	2	2	23
4	Engineering	1	1	135
5	Natural Sciences	1	1	21

Ester Fonsatti

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma Maria Colombino, Mariaelena Capone, Amelia Lissia, Journal of Clinical Oncology	2012	453
Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial Luana Calabrò, Aldo Morra, Ester Fonsatti, The Lancet Oncology Surgical OncologyMalignant DiseaseMedicineCancer ManagementPathology	2013	353
Ipilimumab and fotemustine in patients with advanced melanoma (NIBIT-M1): an open-label, single-arm phase 2 trial Anna Maria Di Giacomo, Paolo A. Ascierto, Lorenzo Pilla, The Lancet Oncology OncologySingle-arm Phase 2MelanomaImmune Checkpoint InhibitorPharmacotherapy	2012	280
Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma and peritoneal fluid from ovarian cancer patients Antonia Anna Anzalone, Lucia Lettini, Ester Fonsatti, The Women s Oncology Review OncologyMedicineGynecologyCancer Cell BiologyPathology	2005	223
Intratumor Heterogeneity of Cancer/Testis Antigens Expression in Human Cutaneous Melanoma Is Methylation-Regulated and Functionally Reverted by 5-Aza-2′-deoxycytidine Luca Sigalotti, Elisabetta Fratta, Sandra Coral, Cancer Research	2004	215
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study Luana Calabrò, Aldo Morra, Ester Fonsatti, The Lancet Respiratory Medicine Surgical OncologyOncologyCancer ManagementIntensified SchedulePathology	2015	203
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer Ester Fonsatti, Michele Maio Journal of Translational Medicine	2004	160
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study Anna Maria Di Giacomo, Paolo A. Ascierto, Paola Queirolo, Annals of Oncology OncologyItalian NetworkMedicineMelanomaClinical Trials	2014	139
Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Ester Fonsatti, Antti Jekunen, Kalevi Kairemo, PubMed Breast OncologyEngineeringEndothelial CellsSolid TumorsOncologic Imaging	2000	135
Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2′-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications Ester Fonsatti, Hugues J. M. Nicolay, Luca Sigalotti, Clinical Cancer Research	2007	135

Page 1